Know anyone interested in health policy/health services research? We are hiring for a research assistant position @HarvardHPM @HarvardChanSPH Pre-grad/pre-meds welcome to apply! @Thomasctsai @ReneeNSalas_MD @LauraBurke20 @mirandalammd @afrakt https://t.co/fJjwhKBd8h

Alternative payment models can and should incentivize reduction of health disparities. We argue how the Radiation Oncology Model @CMSGov can be reformed before 2022 to help close the cancer gap in the US. 🙏@mirandalammd @joefigs2 https://t.co/L7LGsvE40E

Prioritizing health equity in radiation oncology: Miranda Lam, MD MBA (@mirandalammd), of Dana-Farber and @BrighamRadOnc and Parsa Erfani (@ErfaniParsa) explore ways to protect vulnerable populations within the @CMSGove radiation oncology model @astro_org:

New research: Medicaid expansion associated with decreased mortality among newly diagnosed breast, colorectal and lung cancer patients: https://t.co/Hfu7y2HHGP via @JAMANetworkOpen @mirandalammd @ashishkjha @BrighamWomens @HarvardChanSPH

Cardiologists are increasingly leaving smaller practices and joining larger practices over time. Recent health reform efforts (⬆️ regulation, ⬆️ value-based contracts, ⬆️ need for “quality” reporting) likely playing a role. Our new @JACCJournals work @kejoynt @mirandalammd

So I wrote an op-ed in @BostonGlobe about surprise billing I hate it. I Its a moral corruption of our profession Yes its complex. Yes there are times when insurers don't negotiate in good faith But often surprise billing is a business model. And it undermines trust in doctors

Thanks @sprakermdphd! We were surprised by the results of our study led by @DMitra_MD & will be treating more scalp/face #angiosarcomas w/ VMAT. Great initial results for your clinical trial w/ chemoRT. Agree we need to continue to improve outcomes for these patients! #CTOS2019

Nice piece about cancer care in ACOs I missed! Among cancer patients, no significant declines in spending associated with ACOs. Speaks to debate on if global payment is enough, or if we need to tailor programs for some high-cost groups. @mirandalammd https://t.co/bLVotukF49

Excited to present our work on ACOs and cancer care at @AJMC_Journal future of oncology value based care meeting @ashishkjha @joefigs2

Congrats to our awesome #mri guided #radiotherapy team @BrighamWomens /@DanaFarber for scanning our first #cancer patient for treatment planning on the cutting edge MRI-guided linear accelerator (first in New England)! Amazing work! looking forward to first treatments in 2 weeks!

Population Health Management is all the rage....so I wrote about it for @JAMAForum. What's it about? And what's the evidence? In short -- do it because it might save lives, not because it will save money. https://t.co/13SkBEOPNB

Thanks @JAMAOnc for publishing our work on reasons for non-insurance in cancer survivors.TBL: the ACA was successful in increasing insurance rates among cancer survivors - any dismantling of the ACA could be detrimental. @Beam_Doc @mirandalammd @ShaalanBeg

Interesting and important publication. IMO, large databases are better suited to characterize patterns of care, rather than comparing treatment efficacy. Too many unknown confounders for the latter.

**New study in @JAMA_current** We find that implementation of the Hospital Readmissions Reduction Program was associated with ⬆ 30-day post-discharge mortality among patients hospitalized w/ heart failure or pneumonia, but not AMI. @rwyeh @kejoynt https://t.co/4WEepfKyQF

An otherworldly explanation of counterfactuals and diff in diff by the always on point @laura_tastic . #HMSHCP 30th Anniversary Symposium

The #homeless crisis is worsening in US cities. Our new study finds that hospitalizations among homeless adults are also rising. Despite greater policy focus, mental illness & substance use disorders remain the primary drivers (>50%) of hospitalization. https://t.co/iZWzY4pZHx

I'm sensing a new wave of reports on cancer "overtaking" or "surpassing" heart disease as leading cause of death in the US. Here's your friendly reminder that this is a story about which cause of death is decreasing more quickly.

Our @bmj_latest study finds that private accreditation (including The Joint Commission) is not consistently associated with better patient outcomes than when reviewed by state agencies. Time for new metrics to improve value? @ashishkjha @joefigs2 @YFeyman @KimReimold

The @TJCommission accrediting hospitals is supposed to adjudicate quality of care, promote safety and lead to better patient outcomes. A new studiy questions that https://t.co/lRKBFdzsZ8 @bmj_latest #OA @mirandalammd @ashishkjha et al https://t.co/wUbzX3v1xC by @StephArmour1 @WSJ

Key study: ACOs haven't reduced cancer cost. Why? 1 Complicated care 2 Expensive drugs 3 Lack of ACO focus on cancer 4 Cancer value initiatives already reduced cost I'd bet on 2 https://t.co/tev7a0hmp9 @JCO_ASCO @mirandalammd @joefigs2 @ashishkjha @dukemargolis @DukeForge